Fernando Tamez, director of DS Labs, said, "Our mission has always been to improve patient outcomes through dermatological science. Joining Megalabs allows us to expand our reach and impact."
Courtesy of Megalabs
Megalabs has acquired a majority stake of DS Laboratories, further propelling Megalabs' position in the global dermatology market and the United States.
DS Labs will benefit from Megalabs' distribution network and operational expertise, accelerating the development and delivery of new treatments globally.
Fernando Tamez, director of DS Labs, said, "Our mission has always been to improve patient outcomes through dermatological science. Joining Megalabs allows us to expand our reach and impact."
